MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Watch List: Layoffs of 10% or More, Strategic Corporate Review, Delisting, Regulatory, Financial and/or Legal Issues
Elutia Inc. (NASDAQ: ELUT), formerly, Aziyo Biologics Inc (NASDAQ: AZYO)*
Organization & Developments: Aziyo Biologics
Parents
Elutia Inc. (NASDAQ: ELUT), formerly, Aziyo Biologics Inc (NASDAQ: AZYO)*
Children
*Aziyo focuses on developing and commercializing regenerative medicine products.
*Elutia Inc. NASDAQ: ELUT formerly Aziyo Biologics, Inc (AZYO) is focused on developing and commercializing proprietary drug-eluting biomatrix technology aimed at improving surgical outcomes.
2018: U.S. Army_MEDCOM_Notice of Intent for Sole Source for ViBone Cellular Allograft
2020: Aziyo Biologics Finalizes IPO Plan
2025: Boston Scientific inks $88M Elutia deal to challenge Medtronic
2025: Elutia receives Nasdaq notice for non-compliance with market value and bid price rules
2025: Gaithersburg biotech Elutia battles to keep Nasdaq listing after asset sale
Jumps
Finance & Acquisitions: Aziyo Biologics
Key People: Aziyo Biologics